Clemastine Fumarate
Loading...Clemastine Fumarate Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Antihistamines should be used with considerable caution in patients with: narrow angle glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, symptomatic prostatic hypertrophy, and bladder neck obstruction.
Safety and efficacy of clemastine fumarate have not been established in children under the age of 12 years.
Experience with this drug in pregnant women is inadequate to determine whether there exists a potential for harm to the developing fetus.
Clemastine has additive effects with alcohol and other CNS depressants (hypnotics, sedatives, tranquilizers, etc.)
Patients should be warned about engaging in activities requiring mental alertness such as driving a car or operating appliances, machinery, etc.
Antihistamines are more likely to cause dizziness, sedation, and hypotension in elderly patients.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Clemastine fumarate tablets are indicated for the relief of symptoms associated with allergic rhinitis such as sneezing, rhinorrhea, pruritus, and lacrimation.
Clemastine fumarate tablets are also indicated for the relief of mild, uncomplicated allergic skin manifestations of urticaria and angioedema.
It should be noted that clemastine is indicated for the dermatologic indications at the 2.68 mg dosage level only.
History
There is currently no drug history available for this drug.
Other Information
Clemastine fumarate belongs to the benzhydryl ether group of antihistaminic compounds. The chemical name is (+)-2-[-2- [(p-chloro-α-methyl-α-phenylbenzyl) oxy] ethyl]-1-methylpyrrolidine hydrogen fumarate. It has the following structural formula:
Each tablet for oral administration contains 2.68 mg clemastine fumarate. Inactive ingredients include lactose (monohydrate), hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, and starch (corn).
Sources
Clemastine Fumarate Manufacturers
-
Sandoz Inc
![Clemastine Fumarate Tablet [Sandoz Inc]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Clemastine Fumarate | Sandoz Inc
DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND RESPONSE OF THE PATIENT.
The recommended starting dose is 1.34 mg (1/2 tablet) twice daily. Dosage may be increased as required. Clemastine fumarate tablets are recommended for the dermatologic indications at the 2.68 mg dosage level only.
The maximum recommended dosage is 2.68 mg three times daily. Many patients respond favorably to a single dose which may be repeated as required, but not to exceed three tablets daily.
-
Sandoz Inc
Clemastine Fumarate | Sandoz Inc
adults and children 12 years and older:
1 tablet every 12 hours; not more than 2 tablets in 24 hours
children under 12 years:
ask a doctor
-
Physicians Total Care, Inc.
Clemastine Fumarate | Physicians Total Care, Inc.
adults and children 12 years and older:
1 tablet every 12 hours; not more than 2 tablets in 24 hours
children under 12 years:
ask a doctor
-
Teva Pharmaceuticals Usa Inc
Clemastine Fumarate | Teva Pharmaceuticals Usa Inc
DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND RESPONSE OF THE PATIENT.
Clemastine Fumarate Tablets 1.34 mgThe recommended starting dose is one tablet twice daily. Dosage may be increased as required, but not to exceed six tablets daily.
Clemastine Fumarate Tablets 2.68 mgThe maximum recommended dosage is one tablet three times daily. Many patients respond favorably to a single dose which may be repeated as required, but not to exceed three tablets daily.
-
Carilion Materials Management
Clemastine Fumarate | Carilion Materials Management
adults and children 12 years and older:
1 tablet every 12 hours; not more than 2 tablets in 24 hours
children under 12 years:
ask a doctor
-
Northwind Pharmaceuticals, Llc
Clemastine Fumarate | Northwind Pharmaceuticals, Llc
DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND RESPONSE OF THE PATIENT.
Clemastine Fumarate Tablets 1.34 mg
The recommended starting dose is one tablet twice daily. Dosage may be increased as required, but not to exceed six tablets daily.
Clemastine Fumarate Tablets 2.68 mg
The maximum recommended dosage is one tablet three times daily. Many patients respond favorably to a single dose which may be repeated as required, but not to exceed three tablets daily.
![Clemastine Fumarate Tablet [Sandoz Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=0690d8e8-468f-4842-a092-970a315c4d79&name=0690d8e8-468f-4842-a092-970a315c4d79-01.jpg)
![Clemastine Fumarate Tablet [Physicians Total Care, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9aa4a1f9-fb03-4698-a278-4bbb6698b009&name=5913.jpg)
![Clemastine Fumarate Tablet [Teva Pharmaceuticals Usa Inc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=14aaadca-7d86-47e8-8483-6e05d456949d&name=65028f6e-f472-411f-a1b6-01795959f561-02.jpg)
![Clemastine Fumarate Tablet [Carilion Materials Management]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=74f3a9fb-c35e-4720-9538-0a0afe0a773d&name=68151-2456.jpg)
![Clemastine Fumarate Tablet [Northwind Pharmaceuticals, Llc]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=be4f8613-e4da-45e1-a5c0-e9337ca5d245&name=51655-425ClemastineFumarate.jpg)
Login To Your Free Account